Human Genetic Therapies for ALS: Current Status and Future Prospects
By
American Neurological Association
FEATURING
Merit Cudkowicz
By
American Neurological Association
FEATURING
Merit Cudkowicz
Human Genetic Therapies for ALS: Current Status and Future Prospects brought to you from the American Neurological Association’s 149th Annual Meeting featuring Merrit Cudkowicz, MD, MSc, FANA.
Update on status of gene therapies in ALS including FDA-approved treatment (qalsody) and new approaches for SOD1 ALS and other forms of hereditary ALS.
To see more cutting-edge research presented at the ANA2024 meeting, please navigate to https://education.myana.
Comments 0
Login to view comments.
Click here to Login
